UK researchers have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS). MS is a ...

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...

in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy of Neurology 2025 annual meeting. Links to each presentation are included below. Michael S. Weiss, Chief ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for multiple sclerosis (MS). While current treatments prevent further damage ...

Researchers at University College London (UCL) have developed an innovative artificial intelligence (AI) tool called MindGlide, designed to transform the way multiple sclerosis (MS) treatments are ...

More information: Repurposing Clinical MRI Archives for Multiple Sclerosis Research with a Flexible, Single-Contrast Approach: New Insights from Old Scans, Nature Communications (2025). DOI: 10. ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed. A new artificial ...

However, finding the connection was not easy. “It started with the observation that the epidemiology of multiple sclerosis is quite unique because there is a very striking geographical ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

Hauser's work on multiple sclerosis (MS) started more than 45 years ago, when he met a young patient named Andrea, "an extraordinarily talented young woman who was already an attorney" and working ...